← Back to Dashboard

Labyrinthopeptin A1

Interference with viral phospholipid membrane

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC1=CC=C(N1)C(=O)OC2C(C(OC(C2OC)(C)C)OC3=C(C4=C(C=C3)C(=C(C(=O)O4)NC(=…
WTIJXIZOODAMJT-IYKSDEDASA-N
ClinicalTrials.govPubMed

Clinical Development by Virus8

Dengue virus
DENV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Chikungunya virus
CHIKV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Human betaherpesvirus 5
CMV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Hepacivirus C
HCV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Human alphaherpesvirus 1
HSV-1
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Human gammaherpesvirus 8
KSHV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
West Nile virus
WNV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Zika virus
ZIKV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384